The Author’s Reply.
- Published in:
- 2006
- By:
- Publication type:
- Abstract
Works matching IS 03125963 AND DT 2006 AND VI 45 AND IP 8
Results: 8
1
2
Parametric and nonparametric population methods.
- Published in:
- 2006
- By:
- Publication type:
- commentary
3
Comparison of equivalent doses of fentanyl buccal tablets and arteriovenous differences in fentanyl pharmacokinetics.
- Published in:
- 2006
- By:
- Publication type:
- journal article
4
Pharmacokinetics, pharmacodynamics and safety of febuxostat, a non-purine selective inhibitor of xanthine oxidase, in a dose escalation study in healthy subjects.
- Published in:
- 2006
- By:
- Publication type:
- journal article
5
Population pharmacokinetics of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, in atrial fibrillation patients receiving long-term anticoagulation therapy.
- Published in:
- 2006
- By:
- Publication type:
- journal article
6
Lack of pharmacokinetic interaction for ISIS 113715, a 2'-0-methoxyethyl modified antisense oligonucleotide targeting protein tyrosine phosphatase 1B messenger RNA, with oral antidiabetic compounds metformin, glipizide or rosiglitazone.
- Published in:
- 2006
- By:
- Publication type:
- journal article
7
Chronopharmacokinetics of ciclosporin and tacrolimus.
- Published in:
- 2006
- By:
- Publication type:
- journal article
8
Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis.
- Published in:
- 2006
- By:
- Publication type:
- journal article